Outlook Therapeutics reports NORSE EIGHT trial results; shares slump
Outlook Therapeutics, Inc. (NASDAQ: OTLK ), a biopharmaceutical company, today announced preliminary topline results from its NORSE EIGHT clinical trial, which evaluated ONS-5010 f...
JPMorgan sees S&P 500 rising 8% to 6,500 in 2025
JPMorgan set its 2025 price target for the S&P 500 index at 6,500, implying 8% upside potential from current levels. The target is driven by a projected earnings growth of 10% fo...
Tuesday's Insider Activity: Top Buys and Sells in US Stocks on Nov 26
This article summarizes the most significant insider buying and selling activities for US stocks reported on Tuesday, November 26, 2024. Top Insider Buys: • Blue Dolphin Energy Co...
